237 related articles for article (PubMed ID: 32950755)
1. Blockade of Th17 response by IL-38 in primary Sjögren's syndrome.
Luo D; Chen Y; Zhou N; Li T; Wang H
Mol Immunol; 2020 Nov; 127():107-111. PubMed ID: 32950755
[TBL] [Abstract][Full Text] [Related]
2. SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren's syndrome.
Hu P; Cai J; Yang C; Xu L; Ma S; Song H; Yang P
Int Immunopharmacol; 2024 Jan; 126():111282. PubMed ID: 38061117
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
[TBL] [Abstract][Full Text] [Related]
4. Expression of G
Sun Y; Wang Y; Chen S; Fan G; Zhang J; Dai F; Qian H; Liu Y; Shi G
J Immunol Res; 2018; 2018():8212641. PubMed ID: 29977933
[TBL] [Abstract][Full Text] [Related]
5. Th17 cells in primary Sjögren's syndrome: Pathogenicity and plasticity.
Verstappen GM; Corneth OBJ; Bootsma H; Kroese FGM
J Autoimmun; 2018 Feb; 87():16-25. PubMed ID: 29191572
[TBL] [Abstract][Full Text] [Related]
6. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
Liu TT; Zeng XP; Gu ML; Deng AM
Int J Rheum Dis; 2020 May; 23(5):654-660. PubMed ID: 32180363
[TBL] [Abstract][Full Text] [Related]
7. Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome.
Ciccia F; Guggino G; Rizzo A; Ferrante A; Raimondo S; Giardina A; Dieli F; Campisi G; Alessandro R; Triolo G
Ann Rheum Dis; 2012 Feb; 71(2):295-301. PubMed ID: 21979002
[TBL] [Abstract][Full Text] [Related]
8. Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren's syndrome.
Fei Y; Zhang W; Lin D; Wu C; Li M; Zhao Y; Zeng X; Zhang F
Clin Rheumatol; 2014 Apr; 33(4):523-9. PubMed ID: 24420723
[TBL] [Abstract][Full Text] [Related]
9. Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis.
Katsifis GE; Rekka S; Moutsopoulos NM; Pillemer S; Wahl SM
Am J Pathol; 2009 Sep; 175(3):1167-77. PubMed ID: 19700754
[TBL] [Abstract][Full Text] [Related]
10. TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome.
Kwok SK; Cho ML; Her YM; Oh HJ; Park MK; Lee SY; Woo YJ; Ju JH; Park KS; Kim HY; Park SH
Arthritis Res Ther; 2012 Mar; 14(2):R64. PubMed ID: 22417709
[TBL] [Abstract][Full Text] [Related]
11. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.
Zhao L; Nocturne G; Haskett S; Boudaoud S; Lazure T; Le Pajolec C; Mariette X; Mingueneau M; Banerjee D
Rheumatology (Oxford); 2017 Feb; 56(2):303-312. PubMed ID: 27803305
[TBL] [Abstract][Full Text] [Related]
13. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
[TBL] [Abstract][Full Text] [Related]
14. Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.
Ciccia F; Guggino G; Rizzo A; Bombardieri M; Raimondo S; Carubbi F; Cannizzaro A; Sireci G; Dieli F; Campisi G; Giacomelli R; Cipriani P; De Leo G; Alessandro R; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):219-29. PubMed ID: 25880879
[TBL] [Abstract][Full Text] [Related]
15. Activity of T-helper cells in patients with primary Sjogren's syndrome.
Sudzius G; Mieliauskaite D; Butrimiene I; Siaurys A; Mackiewicz Z; Dumalakiene I
In Vivo; 2013; 27(2):263-8. PubMed ID: 23422488
[TBL] [Abstract][Full Text] [Related]
16. Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome.
Ciccia F; Guggino G; Rizzo A; Alessandro R; Carubbi F; Giardina A; Cipriani P; Ferrante A; Cannizzaro A; Giacomelli R; Triolo G
Rheumatology (Oxford); 2014 Jul; 53(7):1313-20. PubMed ID: 24602921
[TBL] [Abstract][Full Text] [Related]
17. IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome.
Alunno A; Bistoni O; Bartoloni Bocci E; Caterbi S; Bigerna B; Pucciarini A; Tabarrini A; Mannucci R; Beghelli D; Falini B; Gerli R
Reumatismo; 2013 Oct; 65(4):192-8. PubMed ID: 24192564
[TBL] [Abstract][Full Text] [Related]
18. Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome.
Alunno A; Ibba-Manneschi L; Bistoni O; Rosa I; Caterbi S; Gerli R; Manetti M
J Cell Mol Med; 2016 Apr; 20(4):613-22. PubMed ID: 26828975
[TBL] [Abstract][Full Text] [Related]
19. Melatonin relieves Th17/CD4
Liu Y; Chen XQ; Wang F; Cheng B; Zhou G
Int Immunopharmacol; 2022 Aug; 109():108778. PubMed ID: 35537347
[TBL] [Abstract][Full Text] [Related]
20. The role of M1/M2 macrophage polarization in primary Sjogren's syndrome.
Chen X; Zhu L; Wu H
Arthritis Res Ther; 2024 May; 26(1):101. PubMed ID: 38745331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]